Delpharm has inaugurated a new sterile filling line at its Saint-Rémy site to commit to French healthcare sovereignty.
With this additional line, fully Annex 1 compliant, Delpharm Saint-Rémy, is significantly increasing its production capacity for sterile vials or freeze-drying with an additional capacity of 45 million units in 2 ml format.

This investment including new building is valued at €37 million including €10.4 million in aid from the French government.

Download the press release for more information.